The efficacy and safety of anti-tnf a treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from turkbio registry
Yükleniyor...
Dosyalar
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
BMJ PUBLISHING GROUP
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
[Abstract not Available]
Açıklama
Annual European Congress of Rheumatology (EULAR) -- JUN 12-15, 2019 -- Madrid, SPAIN
Anahtar Kelimeler
anti-tnf, ankylosing spondylitis
Kaynak
ANNALS OF THE RHEUMATIC DISEASES
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
78
Sayı
Künye
Uslu, S., Can, G., Cefle, A., Yılmaz, S., Kocaer, S. B., İnel, T. Y., Gülle, S., Koca, S. S., Yolbaş, S., Öztürk, M. A., Senel, S., Inanc, N., Dalkılıç, E., Soysal, O., Tufan, A., Akar, S., Birlik, M., Sari, İ., Akkoc, N., Onen, F. (2019). Frı0416 The Efficacy and Safety of Anti-Tnf a Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data From Turkbio Registry. Annals of the Rheumatic Diseases, 78(Suppl 2), 896.
